Here at Qt, we get excited when we see what cool software Qt users come up with. Sometimes they make lives easier, more fun, save money, make us laugh or frown in amused confusion. Finally, there are those that save people's lives and make our hearts swell.
Veriskin, Inc. is a medical device startup company that, in collaboration with our partner Witekio, has developed a novel, inexpensive handheld device for non-invasive skin cancer screening.
Recent clinical studies performed in multiple dermatology clinics across California and Arizona proved that the device can determine whether a skin growth is cancerous within two minutes at an unparalleled 100% sensitivity and 96.7% specificity.
In 2016 Veriskin, Inc. has been awarded an SBIR Phase II grant award by the National Cancer Institute of the National Institutes of Health (NIH).
Cancer detection with this device is also relatively cheap. This might encourage people to sign up for more regular screenings. According to Veriskin, skin cancer causes around 30'000 deaths per year in the US and the EU alone. This is especially tragic considering that most patients could be saved if a melanoma is detected early.
In addition, the device also aims to reduce unnecessary biopsies and dermatologist appointments. Veriskin estimates the saving's potential to the US healthcare industry and insurers alone at $3.2B.
